Market movement
In 2024, heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure: loprazolam (inn), mecloqualone (inn), methaqualone (inn), and zipeprol (inn): salts thereof trade exhibited significant decline, with global flows reaching $1,032,059 and a three-year compound annual growth rate of -17.5% (five-year: -9.7%). The all-time peak of $318,705,134 was recorded in 2002; the current level is 100% below that high-water mark.
Over the 30-year observation window (1995–2024), 41% of years recorded positive growth, indicating significant cyclicality with frequent contractions. Trend momentum is decelerating (-7.5% acceleration).
